These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The effect of eliprodil on the evolution of a focal cerebral ischaemia in vivo. Ibarrola D; Seegers H; Jaillard A; Hommel M; Décorps M; Massarelli R Eur J Pharmacol; 1998 Jul; 352(1):29-35. PubMed ID: 9718264 [TBL] [Abstract][Full Text] [Related]
23. Effects of NMDA receptor antagonists on cocaine-conditioned motor activity in rats. Bespalov AY; Dravolina OA; Zvartau EE; Beardsley PM; Balster RL Eur J Pharmacol; 2000 Mar; 390(3):303-11. PubMed ID: 10708738 [TBL] [Abstract][Full Text] [Related]
24. Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices. Mallon AP; Auberson YP; Stone TW Exp Brain Res; 2005 Apr; 162(3):374-83. PubMed ID: 15580338 [TBL] [Abstract][Full Text] [Related]
25. The effect of CGX-1007 and CI-1041, novel NMDA receptor antagonists, on NMDA receptor-mediated EPSCs. Barton ME; White HS; Wilcox KS Epilepsy Res; 2004 Mar; 59(1):13-24. PubMed ID: 15135163 [TBL] [Abstract][Full Text] [Related]
26. EMD 95885, a new eliprodil analogue with higher affinity for the N-methyl-D-aspartate (NMDA) receptor. Leibrock J; Prücher H; Rautenberg W Pharmazie; 1997 Jun; 52(6):479-80. PubMed ID: 9260271 [No Abstract] [Full Text] [Related]
30. The NMDA/glycine receptor antagonist, L-701,324, produces discriminative stimuli similar to those of ethanol. Kotlinska J; Liljequist S Eur J Pharmacol; 1997 Jul; 332(1):1-8. PubMed ID: 9298919 [TBL] [Abstract][Full Text] [Related]
31. Design and synthesis of a novel water-soluble NMDA receptor antagonist with a 1,4,7,10-tetraazacyclododecane group. Masuko T; Metori K; Kizawa Y; Kusama T; Miyake M Chem Pharm Bull (Tokyo); 2005 Apr; 53(4):444-7. PubMed ID: 15802850 [TBL] [Abstract][Full Text] [Related]
32. N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats. Bespalov AY; Balster RL; Beardsley PM J Pharmacol Exp Ther; 1999 Jul; 290(1):20-7. PubMed ID: 10381755 [TBL] [Abstract][Full Text] [Related]
36. Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Layer RT; Popik P; Olds T; Skolnick P Pharmacol Biochem Behav; 1995 Nov; 52(3):621-7. PubMed ID: 8545484 [TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and biological evaluation of tricyclic heterocycle-tetraamine conjugates as potent NMDA channel blockers. Takayama H; Yaegashi Y; Kitajima M; Han X; Nishimura K; Okuyama S; Igarashi K Bioorg Med Chem Lett; 2007 Sep; 17(17):4729-32. PubMed ID: 17624774 [TBL] [Abstract][Full Text] [Related]
38. NR2B selective NMDA antagonists: the evolution of the ifenprodil-type pharmacophore. Borza I; Domány G Curr Top Med Chem; 2006; 6(7):687-95. PubMed ID: 16719809 [TBL] [Abstract][Full Text] [Related]
39. Insights into structure-activity relationships and CNS therapeutic applications of NR2B selective antagonists. Beinat C; Banister S; Moussa I; Reynolds AJ; McErlean CS; Kassiou M Curr Med Chem; 2010; 17(34):4166-90. PubMed ID: 20939817 [TBL] [Abstract][Full Text] [Related]
40. CP-101,606, an NR2B subunit selective NMDA receptor antagonist, inhibits NMDA and injury induced c-fos expression and cortical spreading depression in rodents. Menniti FS; Pagnozzi MJ; Butler P; Chenard BL; Jaw-Tsai SS; Frost White W Neuropharmacology; 2000 Apr; 39(7):1147-55. PubMed ID: 10760358 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]